**Core Concept:**
Adenosine is an endogenous nucleoside that modulates various physiological processes, including inflammation, immune response, and vascular permeability. Extracellular adenosine levels can be influenced by enzymes like adenosine deaminase (ADA) and ecto-5'-nucleotidase (CD73) that convert adenosine to inosine and AMP, respectively.

**Why the Correct Answer is Right:**
The correct answer is **D:** Methotrexate (MTX). Methotrexate is a well-known disease-modifying antirheumatic drug (DMARD) that acts by inhibiting enzymes involved in purine synthesis, particularly dihydrofolate reductase. This inhibition leads to a reduction in intracellular adenosine monophosphate (AMP), which in turn increases extracellular adenosine levels.

**Why Each Wrong Option is Incorrect:**

A. Hydroxychloroquine (HCQ) is a DMARD that works by inhibiting lysosomal enzyme function, particularly in autoimmune diseases. It does not affect adenosine levels.

B. Azathioprine (AZA) is an immunosuppressive agent that inhibits inosine monophosphate dehydrogenase (IMPDH) and purine synthesis. However, it does not specifically increase adenosine levels.

C. Leflunamide (LEF) is a DMARD that inhibits dihydrofolate reductase (DHFR), similar to methotrexate. However, its mechanism of action is different from methotrexate and does not involve adenosine levels.

**Clinical Pearl:**
Understanding the pharmacology of methotrexate is essential for its effective use in treating autoimmune diseases like rheumatoid arthritis and psoriasis. Methotrexate acts through various mechanisms, including inhibition of DNA synthesis, activation of apoptosis, and suppression of cytokine production. Elevated extracellular adenosine levels are just one aspect of its pharmacology, but they contribute to its anti-inflammatory and immunosuppressive effects.

**Why to Remember:**
Adenosine is a potent anti-inflammatory molecule that can inhibit inflammation, leukocyte chemotaxis, and neutrophil function. Elevated extracellular adenosine levels can be a result of DMARDs like methotrexate, which indirectly enhances adenosine's anti-inflammatory effects.